Conley Chee
Chief Executive Officer bei SYROS PHARMACEUTICALS, INC.
Vermögen: 120 396 $ am 31.03.2024
Profil
Conley Chee is currently the President & Chief Executive Officer at Syros Pharmaceuticals, Inc. He previously worked at Novartis Pharmaceuticals as the Global Head-Portfolio Management.
Mr. Chee completed his undergraduate degree at the University of Alberta and holds an MBA from the Richard Ivey School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.04.2024 | 22 504 ( 0,09% ) | 120 396 $ | 31.03.2024 |
Aktive Positionen von Conley Chee
| Unternehmen | Position | Beginn |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Chief Executive Officer | 02.12.2023 |
Ehemalige bekannte Positionen von Conley Chee
| Unternehmen | Position | Ende |
|---|---|---|
Novartis Pharmaceuticals
 Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The private company is based in Basel, Germany. | Corporate Officer/Principal | - |
Ausbildung von Conley Chee
| University of Alberta | Undergraduate Degree |
| Richard Ivey School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The private company is based in Basel, Germany. | Health Technology |
